Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Syrup Franchise in Ahmedabad

Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Syrup Supplier in Mumbai

Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Syrup Distributor in Delhi

Pediatric Cough & Respiratory Syrup Franchise Opportunity in Bangalore

Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Syrup Stockist in Hyderabad
Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Syrup Export & Manufacturing in Chandigarh

Home/Products /ambroxol-10mg-terbutaline-0-5mg-guaiphensin-25mg

About the Product

Description


Cufstuff Am Junior Syrup contains Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg, a pediatric combination therapy for cough, bronchial congestion, and respiratory discomfort. It helps relieve mucus buildup, wheezing, and irritation in children.

Ambroxol acts as a mucolytic to thin and loosen mucus, Terbutaline provides bronchodilation for easier breathing, and Guaiphenesin works as an expectorant to support mucus clearance. This synergistic combination ensures effective relief from cough and congestion.

The syrup formulation ensures accurate pediatric dosing, palatability, and improved compliance. Cufstuff Am Junior Syrup is widely recommended by pediatricians for mild to moderate respiratory conditions, making it a high-demand pediatric respiratory product.

Adding Cufstuff Am Junior Syrup to your pediatric respiratory therapy segment strengthens your portfolio with a trusted cough and bronchial relief solution. Its prescriber preference, consistent demand, and suitability for domestic and export markets make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include mild nausea, vomiting, headache, or increased heart rate. Rare but serious side effects include severe allergic reactions, tremors, arrhythmias, or excessive nervousness. Medical attention should be sought if any severe or persistent symptoms occur.

Cufstuff Am Junior Syrup is indicated for the relief of cough, bronchospasm, wheezing, and other respiratory symptoms associated with conditions like bronchitis, asthma, and other obstructive airway disorders in children, as prescribed by a healthcare professional.

Cufstuff Am Junior Syrup should be used exactly as prescribed, with careful measurement of doses using the provided device. Caution is advised in children with heart disease, high blood pressure, or thyroid disorders. Do not exceed the recommended dose.

Store Cufstuff Am Junior Syrup in a cool, dry place away from direct sunlight. Keep out of reach of children. Shake well before use and follow storage instructions after opening. Do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ambroxol 10mg + Terbutaline 0.5mg + Guaiphenesin 25mg Tablet/Syrup in the PCD pharma franchise market?

This respiratory combination has strong demand in the cough and chest congestion segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on respiratory care portfolios.

Why should medical distributors include this combination product in their range?

Medical distributors and agencies can benefit from consistent demand for treatment of productive cough, bronchitis, asthma, COPD, and chest congestion with mucus. Ambroxol helps break and thin mucus, Guaiphenesin improves mucus expulsion, and Terbutaline relaxes airway muscles to ease breathing, strengthening a complete respiratory therapy portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this combination with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong respiratory seasonal demand, high physician prescription flow, fast-moving respiratory category, reliable supply chain support, and good margins when partnering for this combination product.

How can I become a distributor or franchise partner for this product?

Medical distributors, stockists, and wholesalers interested in this combination can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.